Tarik Skubal is the kind of pitcher who makes a perfectly reasonable front office start spouting bad ideas.
Which, honestly, makes sense. Skubal is one of Major League Baseball’s best left-handed aces, a two-time reigning American League Cy Young Award winner, and one of the few starters in baseball who could make a great team feel meaningfully scarier the second he walked through the clubhouse door. Before landing on the injured list, Skubal had a 3-2 record, 2.70 ERA, 0.95 WHIP, and 45 strikeouts over 43 1/3 innings. He was not exactly getting by on smoke, mirrors, and Comerica Park’s notoriously spacious outfield.
But those numbers, while brilliant, do not add up to “the Braves should sell the farm for him before the trade deadline.” Let’s explore.
Why the Braves Should Not Trade for Tarik Skubal
The case for trading for Skubal is easy (too easy, really). The Braves are 42-20 after Wednesday night’s 7-3 win over the Toronto Blue Jays, own the majors’ best record, and are now 17-2-1 in series play. They have also won six of their last eight games, which is a pretty useful reminder that this is not a team gasping for oxygen in early June. They’ve turned journeyman Dominic Smith into a revelation, seen Matt Olson’s consecutive games streak reach historic levels, and boasted four legitimate MVP candidates early in the year.
So, sure, adding Skubal sounds wonderful. Chris Sale and Skubal at the front of a playoff rotation sounds nasty and generally unfair to other teams. The kind of thing that looks terrific in a deadline headline and even better in a television graphic before Game 1.
Factors to Consider
Of course, that situation will come with a price. That price? Trading premium young talent for a pitcher coming off arthroscopic elbow surgery, making $32 million this season, and approaching free agency.
Skubal’s medical news has been encouraging, but it is still a notable mitigating factor in this conversation. He had loose bodies removed from his left elbow on May 6, with no ligament damage found, then threw a 64-pitch simulated game Monday in which Tigers manager A.J. Hinch said his velocity looked normal. Again: encouraging. Also, still an elbow surgery for a starting pitcher in the same season Atlanta would be acquiring him, which should matter more than the name.
The Braves’ current roster also undercuts the desperation argument. Sale has looked like a legitimate top-end starter again, Bryce Elder has been amazing in a bounce-back 2026 season, and Grant Holmes just added another useful data point on Wednesday night.
Holmes improved to 4-2 after giving Atlanta five innings of two-run ball against Toronto, and the Braves’ bullpen handled the rest well enough, with Dylan Lee, Robert Suarez, and Tyler Kinley finishing the game.
That came one night after Elder improved to 5-3 in Atlanta’s 4-3 win over the Blue Jays, with Raisel Iglesias earning his 11th save. In other words, the Braves are not sitting around hoping one blockbuster fixes a broken pitching staff. They are stacking wins with the arms they already have.
Would Skubal make the Braves better? Certainly. But that’s not really the question.
The Real Question To Ask
The real question is whether the upgrade is worth the cost. Detroit entered the week buried in the AL Central race, and if the Tigers remain stuck there by July, they should at least listen on Skubal. That does not mean they should hand him to Atlanta at a polite discount. If Skubal looks healthy by July, Detroit can ask for a monster package. If he does not look healthy, the Braves should not want the risk. That is the uncomfortable math.
Atlanta should definitely put out feelers on Skubal’s availability. Alex Anthopoulos should know the price. He should make Detroit say the painful number out loud, then probably let some other contender get seduced by Skubal’s back-to-back Cy Young Awards glinting in the trophy case.
The Braves are good enough to chase a title without turning one short-term pitcher into the center of their deadline. They may need bullpen depth, a right-handed bat, bench protection, or a less expensive rotation stabilizer. What they do not need is to pay “full ace freight” for two months and October of Skubal, especially with a fresh elbow surgery in the recent past.
Skubal is great, but that does not mean the Braves should make the mistake of acquiring him at the deadline.
Main Photo Credit: © Junfu Han / USA TODAY NETWORK via Imagn Images
